PTSM: Pharmaceutical Technology Sourcing and Management
WellSpring Pharma Services has announced the appointment of David Mayers as president.
WellSpring Pharma Services has announced the appointment of David Mayers as president. Mayers brings 25 years of pharmaceutical manufacturing experience, most recently as vice president manufacturing operations at Purdue Pharma.
In the president’s role, Mayers will be responsible for activities associated with the Pharma Services business unit, overseeing plant operations, business development, and quality and regulatory affairs.
Mayers holds a Master’s degree in business administration the University of Toronto and has held leadership positions in manufacturing, quality, research and development, supply chain, operations, project management and strategy. In 11 years at Purdue, he oversaw the expansion of the facility, implemented a lean environment, and facilitated a corporate quality management system supporting global regulatory readiness of the Canadian facility.
WellSpring Pharma Services provides pharmaceutical contract manufacturing and packaging services for solid and semisolid dosage form products.
Source: WellSpring Pharma Services
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.